The N terminus of SMRT is dispensable for synergistic coactivation of ERα by SRC-3 and SMRT. A, Schematic representation of SMRTτ and SMRTshort illustrating repression domains (black box) and CoRNR box motifs (striped box). The 47-amino-acid splice deletion in the C-terminal region of both SMRTτ and SMRTshort adjacent to ID1 is represented as a single horizontal line. The arrow indicates the location of the sequence targeted by this SMRT siRNA (Sαβ2). B, Representative Western blot analysis of SMRT (top) or actin (bottom) expression in cells obtained from HeLa cells transfected in parallel. C, HeLa cells were transfected with negative control (−) siRNA or the Sαβ2 (+) siRNA directed against SMRT before transfection with vectors for ERα, ERE-E1b-Luc, and either 500 ng SMRTshort or control (pCR3.1) expression vector followed by treatment with vehicle or 1 nm E2 for 24 h. The Mr of SMRTshort is approximately 175 kDa. Values represent the average ± sem of three independent experiments. *, P < 0.01 in comparison with control E2 values. D, HeLa cells were transfected with 250 ng expression vectors for control, SMRTshort, or SRC-3 alone or in combination in addition to ERα and ERE-E1b-Luc. Cells were subsequently treated with vehicle or E2 for 24 h. Values represent the average ± sem of four independent experiments. *, P < 0.01 in comparison with control E2 values.